443.64
price down icon2.36%   -10.74
pre-market  プレマーケット:  442.81   -0.83   -0.19%
loading

Alnylam Pharmaceuticals Inc (ALNY) 最新ニュース

pulisher
Aug 19, 2025

Alnylam Pharmaceuticals' Insider Sales: Compliance-Driven Moves or Subtle Signals of Strategic Shift? - AInvest

Aug 19, 2025
pulisher
Aug 19, 2025

Alnylam Pharmaceuticals: Insider Selling as a Signal of Discipline, Not Distrust - AInvest

Aug 19, 2025
pulisher
Aug 19, 2025

Insider Selling at Alnylam Pharmaceuticals: A Closer Look at Implications for Investors - AInvest

Aug 19, 2025
pulisher
Aug 19, 2025

Alnylam EVP Garg sells $1.3 million in stock - Investing.com

Aug 19, 2025
pulisher
Aug 19, 2025

Three Companies That Might Be Priced Below Their Estimated Value - simplywall.st

Aug 19, 2025
pulisher
Aug 19, 2025

Insider Selling at Alnylam Pharmaceuticals: Profit-Taking or a Warning Sign? - AInvest

Aug 19, 2025
pulisher
Aug 18, 2025

Alnylam Shares Surge on $730M Volume After FDA Approval Boosts Market Outlook and Analysts Raise Targets - AInvest

Aug 18, 2025
pulisher
Aug 18, 2025

Why Alnylam Pharmaceuticals Inc. stock attracts strong analyst attentionWall Street Watch & Scalable Portfolio Growth Ideas - beatles.ru

Aug 18, 2025
pulisher
Aug 18, 2025

Alnylam Pharmaceuticals, Inc. (ALNY) Gets EU Nod for AMVUTTRA - MSN

Aug 18, 2025
pulisher
Aug 18, 2025

Alnylam Pharmaceuticals’ SWOT analysis: stock poised for growth amid ATTR-CM market expansion - Investing.com

Aug 18, 2025
pulisher
Aug 18, 2025

Free Genetic Tests May Aid People With Rare Kidney Disease - Medscape

Aug 18, 2025
pulisher
Aug 17, 2025

Insider Selling Trends in Nasdaq-Listed Companies: A Cautionary Lens on Alnylam, Boston Scientific, and CSX - AInvest

Aug 17, 2025
pulisher
Aug 16, 2025

Alnylam, Halozyme among latest firms to win EU backing for drugs - MSN

Aug 16, 2025
pulisher
Aug 15, 2025

Alnylam Pharmaceuticals Inc. Reversal Rally May Surprise Bears2025 Market Overview & Technical Buy Zone Confirmations - beatles.ru

Aug 15, 2025
pulisher
Aug 15, 2025

Alnylam Pharmaceuticals stock hits all-time high at 445.44 USD By Investing.com - Investing.com Australia

Aug 15, 2025
pulisher
Aug 15, 2025

Alnylam Pharmaceuticals stock hits all-time high at 445.44 USD - Investing.com

Aug 15, 2025
pulisher
Aug 14, 2025

Alnylam Gains 2.36% on FDA Support and Buy Rating as Top 500 Volume Strategy Yields 31.52% Return - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Alnylam Raises 2025 Revenue Guidance as Losses Widen Might Change The Case For Investing In ALNY - simplywall.st

Aug 14, 2025
pulisher
Aug 13, 2025

Alnylam’s Trading Volume Surges 38.6% to Rank 113th in Market Activity - AInvest

Aug 13, 2025
pulisher
Aug 13, 2025

Promising Biotech Stocks Worth WatchingAugust 12th - MarketBeat

Aug 13, 2025
pulisher
Aug 13, 2025

Here's How Much $100 Invested In Alnylam Pharmaceuticals 10 Years Ago Would Be Worth Today - 富途牛牛

Aug 13, 2025
pulisher
Aug 13, 2025

Why Alnylam Pharmaceuticals Inc. stock attracts strong analyst attention [2025 Valuation Update]Low Risk Entry Point Tips - sisaissue.com

Aug 13, 2025
pulisher
Aug 12, 2025

Alnylam’s $650M Volume Ranks 168th as Shares Drop 1.17% Pre-ESC Data Presentation - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Alnylam at Canaccord Genuity: Strategic Growth and Innovation By Investing.com - Investing.com Nigeria

Aug 12, 2025
pulisher
Aug 12, 2025

Alnylam at Canaccord Genuity: Strategic Growth and Innovation - Investing.com

Aug 12, 2025
pulisher
Aug 12, 2025

Alnylam’s Vutrisiran Study: A Potential Game-Changer for Cardiomyopathy Treatment - TipRanks

Aug 12, 2025
pulisher
Aug 12, 2025

Alnylam Pharmaceuticals at Canaccord Genuity's 45th Annual Growth Conference - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Alnylam to Present Progress in Transforming the Treatment of Cardiovascular Disease with RNAi Therapeutics at European Society of Cardiology Congress 2025 - BioSpace

Aug 12, 2025
pulisher
Aug 11, 2025

Profits May Be Just Around the Corner for This Strong-Buy Pharma Stock - Yahoo Finance

Aug 11, 2025
pulisher
Aug 11, 2025

Possible Bearish Signals With Alnylam Pharmaceuticals Insiders Disposing Stock - Yahoo Finance

Aug 11, 2025
pulisher
Aug 10, 2025

Alnylam Pharmaceuticals (ALNY) Is Up 9.2% After Upward Q2 Revenue Guidance Revision and Higher Analyst Forecasts—Has the Bull Case Changed? - simplywall.st

Aug 10, 2025
pulisher
Aug 10, 2025

Alnylam Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Recent Period Progress - ADVFN Brasil

Aug 10, 2025
pulisher
Aug 07, 2025

Alnylam Gains 1.63% on Surging Amvuttra Sales Hits 233rd in Market Activity - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Alnylam Pharma: Strong Commercial Performance and Promising Pipeline Drive Buy Rating - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

Does Alnylam’s (ALNY) Upbeat Revenue Forecast Signal Shifting Momentum in Its Long-Term Growth Story? - simplywall.st

Aug 07, 2025
pulisher
Aug 07, 2025

Vir (VIR) Q2 Revenue Drops 61% - The Motley Fool

Aug 07, 2025
pulisher
Aug 06, 2025

Alnylam Rises 2.2% on 17% Revenue Surge and Analyst Upgrades Despite 220th-Ranked 0.5B Volume Drop - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

Alnylam Pharmaceuticals stock hits all-time high at $427.0 USD - Investing.com

Aug 06, 2025
pulisher
Aug 06, 2025

Alnylam Pharmaceuticals stock hits all-time high at $427.0 USD By Investing.com - Investing.com Canada

Aug 06, 2025
pulisher
Aug 06, 2025

Nxera debuts an obesity pipeline; BridgeBio battles Alnylam for market share - BioPharma Dive

Aug 06, 2025
pulisher
Aug 05, 2025

Alnylam Slips 0.15% Despite $760M Volume Ranking 137th in U.S. Equities as Mixed Pipeline Data Weigh on Momentum - AInvest

Aug 05, 2025
pulisher
Aug 05, 2025

Alnylam’s Amvuttra Sales Leave Forecasts In The Dust - Finimize

Aug 05, 2025
pulisher
Aug 05, 2025

Alnylam to Webcast Presentation at Canaccord Genuity 45th Annual Growth Conference - Business Wire

Aug 05, 2025
pulisher
Aug 05, 2025

Alnylam Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations - simplywall.st

Aug 05, 2025
pulisher
Aug 05, 2025

Analyst Forecasts For Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Are Surging Higher - Yahoo Finance

Aug 05, 2025
pulisher
Aug 05, 2025

U.S. Transthyretin Amyloidosis Treatment Market Exclusive - openPR.com

Aug 05, 2025
pulisher
Aug 04, 2025

Health Care Stocks See Gains On Strong Results And Approvals - Finimize

Aug 04, 2025
pulisher
Aug 04, 2025

Wolfe Research upgrades Alnylam Pharmaceuticals stock rating to Peerperform By Investing.com - Investing.com Canada

Aug 04, 2025
pulisher
Aug 04, 2025

Oppenheimer upgrades Alnylam stock to Outperform on strong Amvuttra sales By Investing.com - Investing.com Canada

Aug 04, 2025
pulisher
Aug 04, 2025

Earnings Estimates Rising for Alnylam (ALNY): Will It Gain? - Yahoo Finance

Aug 04, 2025
pulisher
Aug 04, 2025

Alnylam Pharmaceuticals Surges 3.79% Intraday – What’s Fueling This Sudden Rally? - AInvest

Aug 04, 2025
pulisher
Aug 04, 2025

Alnylam's Amvuttra Sales Exceeding Expectations by Sizable Margin, Oppenheimer Says - MarketScreener

Aug 04, 2025
pulisher
Aug 04, 2025

Are Medical Stocks Lagging ADC Therapeutics (ADCT) This Year? - Yahoo Finance

Aug 04, 2025
pulisher
Aug 04, 2025

This Alnylam Pharmaceuticals Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday - Benzinga

Aug 04, 2025
pulisher
Aug 04, 2025

Why Alnylam Pharmaceuticals (ALNY) Is Up 23.7% After Raising 2025 Revenue Outlook on AMVUTTRA Growth - simplywall.st

Aug 04, 2025
pulisher
Aug 04, 2025

What are analysts’ price targets for Alnylam Pharmaceuticals Inc. in the next 12 monthsTremendous growth potential - Jammu Links News

Aug 04, 2025
pulisher
Aug 03, 2025

When is Alnylam Pharmaceuticals Inc. stock expected to show significant growthDiscover top stock picks for aggressive growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Alnylam Pharmaceuticals Inc. compare to its industry peersUnmatched market performance - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are the latest earnings results for Alnylam Pharmaceuticals Inc.Free Capital Efficiency Planning - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Does Alnylam Pharmaceuticals Inc. stock perform well during market downturnsCapitalize on momentum-driven investment opportunities - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Alnylam Pharmaceuticals Inc. generate profit in a changing economyConsistently superior profits - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What makes Alnylam Pharmaceuticals Inc. stock price move sharplyUnlock powerful stock screening tools today - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How volatile is Alnylam Pharmaceuticals Inc. stock compared to the marketCapitalize on strong market momentum - Jammu Links News

Aug 03, 2025
$572.38
price down icon 2.90%
$677.32
price up icon 2.62%
biotechnology ONC
$308.63
price down icon 1.61%
$128.32
price down icon 2.70%
$105.07
price down icon 5.24%
大文字化:     |  ボリューム (24 時間):